-

Humana Inc. to Present at the BofA Securities 2023 Healthcare Conference

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, President and Chief Executive Officer, and Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at the BofA Securities Healthcare Conference on Tuesday, May 9, 2023, at 8:40 a.m. Pacific time.

A live audio webcast of the presentation will be available via Humana’s Investor Relations page at humana.com. The company suggests webcast participants sign on approximately 15 minutes in advance of the presentation to allow time to run a system test and download any free software needed for access purposes.

About Humana

Humana Inc. (NYSE: HUM) is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at humana.com, including copies of:

  • Annual reports to stockholders
  • Securities and Exchange Commission filings
  • Most recent investor conference presentations
  • Quarterly earnings news releases
  • Calendar of events
  • Corporate Governance information

Contacts

Lisa Stoner
Humana Investor Relations
(502) 580-2652
e-mail: lstamper@humana.com

Mark Taylor
Humana Corporate Communications
(317) 753-0345
e-mail: mtaylor108@humana.com

Humana Inc.

NYSE:HUM

Release Versions

Contacts

Lisa Stoner
Humana Investor Relations
(502) 580-2652
e-mail: lstamper@humana.com

Mark Taylor
Humana Corporate Communications
(317) 753-0345
e-mail: mtaylor108@humana.com

More News From Humana Inc.

Humana Announces Insurance Leadership Transition

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced that George Renaudin, Insurance Segment President and member of Humana’s Enterprise Leadership Team, will retire by Q3 2026 following a successful 29-year career at the company. During this period, Renaudin played a pivotal role in establishing and growing Humana’s Medicare Advantage and Medicaid programs, helping to build them into high-performing businesses and assembling a strong insurance leadership team. “George has...

Humana Inc. to Present at 2025 Wolfe Research Healthcare Conference

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Celeste Mellet, Chief Financial Officer, will make a presentation to investors at the Wolfe Research Healthcare Conference on Wednesday, November 19, 2025, at 8:40 a.m. Eastern time. A live audio webcast of the presentation will be available via Humana’s Investor Relations page at https://humana.gcs-web.com/. The company suggests webcast participants sign on approximately 15 minutes in advance of the presentation to...

Humana Reports Third Quarter 2025 Financial Results; Affirms Full Year 2025 Adjusted EPS Guidance

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended September 30, 2025 (3Q25) versus the quarter ended September 30, 2024 (3Q24) and for the nine months ended September 30, 2025 (YTD 2025) versus the nine months ended September 30, 2024 (YTD 2024) as noted in the tables below. Consolidated income before income taxes and equity in net losses (pretax results) in millions 3Q25 (a) 3Q24 (a) Y...
Back to Newsroom